Recent Articles

The Global Economic Burden of Tobacco: An Interview with Dr. Mark Parascandola

| January 18, 2017 | 0 Comments

The Global Economic Burden of Tobacco: An Interview with Dr. Mark Parascandola NCI’s Dr. Mark Parascandola answers questions about The Economics of Tobacco and Tobacco Control, the latest in a series of monographs on tobacco use and tobacco control, which was co-written with the World Health Organization.See Original Article

Continue Reading

Olanzapine Helps Prevent Nausea and Vomiting Caused by Chemotherapy

| January 17, 2017 | 0 Comments

Olanzapine Helps Prevent Nausea and Vomiting Caused by Chemotherapy A drug currently used to treat several psychiatric conditions can help prevent nausea and vomiting in patients receiving chemotherapy, a large clinical trial showed.See Original Article New on NCI Websites for October 2016 An NCI Cancer Currents blog post that provides updates on new NCI websites […]

Continue Reading

More Immunotherapy Options Approved for Lung Cancer

| January 16, 2017 | 0 Comments

More Immunotherapy Options Approved for Lung Cancer The FDA has approved atezolizumab and expanded the approval of pembrolizumab for some patients with non-small cell lung cancer. See Original Article What’s New on NCI’s Websites? NCI periodically provides updates on new websites and other online content of interest to the cancer community.See Original Article The Cancer […]

Continue Reading

Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer

| January 14, 2017 | 0 Comments

Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer In a small clinical trial, more than half of the patients with an aggressive form of skin cancer called Merkel cell carcinoma responded to the immunotherapy drug pembrolizumab.See Original Article Early-Stage Cancer Trials Support Promise of Precision Medicine, Immunotherapy Encouraging findings from several early-stage […]

Continue Reading

Blue Ribbon Panel Report: The Power of the Cancer Community Coming Together

| January 11, 2017 | 0 Comments

Blue Ribbon Panel Report: The Power of the Cancer Community Coming Together NCI Acting Director Dr. Douglas R. Lowy, M.D., thanks the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.See Original Article DINO RNA Molecule Triggers Anticancer Response in […]

Continue Reading

Nanotechnology for Treating Cancer: Pitfalls and Bridges on the Path to Nanomedicines

| January 11, 2017 | 0 Comments

Nanotechnology for Treating Cancer: Pitfalls and Bridges on the Path to Nanomedicines Despite their promise, only a few nano-formulated drugs are used in humans. The NCI Nanotechnology Characterization Lab helps companies and academic investigators maximize their chance of successful clinical use.See Original Article Grantee Spotlight: Julie Dang, M.P.H. – Personalizing Outreach to Address Asian Cancer […]

Continue Reading

A Conversation with Arul Chinnaiyan

| January 11, 2017 | 0 Comments

A Conversation with Arul Chinnaiyan Arul Chinnaiyan and colleagues discovered a strong interaction between the KRAS and AGO2 proteins that seems to inhibit KRAS signaling. They are also pioneers in using genomic data to guide therapy for cancer patients.See Original Article Program Spotlight: Partnership for the Advancement of Cancer Research Project Brings Cancer Research Training […]

Continue Reading

Program Spotlight: National Outreach Network's Community Health Educators Provide Much-Needed Support to Cancer Survivors from Racially/Ethnically Diverse Communities

| January 11, 2017 | 0 Comments

Program Spotlight: National Outreach Network's Community Health Educators Provide Much-Needed Support to Cancer Survivors from Racially/Ethnically Diverse Communities National Outreach Network of Community Health Educators located at Community Network Program Centers, Partnerships to Advance Cancer Health Equity, and NCI-designated cancer centers help patients and their families receive survivorship support.See Original Article Precision Medicine Trials for […]

Continue Reading

Quantitative Assays for RAS Pathway Proteins and Phosphorylation States

| January 11, 2017 | 0 Comments

Quantitative Assays for RAS Pathway Proteins and Phosphorylation States The NCI CPTAC program is applying its expertise in quantitative proteomics to develop assays for RAS pathway proteins. Targets include key phosphopeptides that should increase our understanding of how the RAS pathway is regulated.See Original Article Pancreatic Organoids – A Conversation with Senthil Muthuswamy Pancreatic cancer […]

Continue Reading

Nutritional Requirements of Pancreatic Cancers – A Conversation with Dafna Bar-Sagi

| January 11, 2017 | 0 Comments

Nutritional Requirements of Pancreatic Cancers – A Conversation with Dafna Bar-Sagi Solid tumors in humans develop primarily from epithelial cells, which have different functions in different tissues. Pancreatic cancers derive much of their nutrition from proteins consumed from their environment.See Original Article Program Spotlight: Dana Farber/Harvard Cancer Center Partnership Receives $8 Million Grant to Start […]

Continue Reading